Cole Douglas G. 4
4 · Sigilon Therapeutics, Inc. · Filed Jun 28, 2021
Insider Transaction Report
Form 4
Cole Douglas G.
Director
Transactions
- Award
Stock Option (Right to Buy)
2021-06-24$9.97/sh+8,888$88,613→ 8,888 totalExercise: $9.97Exp: 2031-06-23→ Common Stock (8,888 underlying)
Footnotes (1)
- [F1]The option was issued pursuant to the Sigilon Therapeutics, Inc. 2020 Equity Incentive Plan. The option will vest as to 100% on June 24, 2022.